EP171/#1044 Beside breast/ovarian malignancy: other cancer risk profile in BRCA1 and BRCA2 pathogenic variants

Gabriel Levin, Tamar Peretz, Liron Kogan, Benny Brandt, Tamar Hamburger, Tamar Perri
2022 E-Posters   unpublished
105, 18%), does not want to discuss GT with family (55, 9%), relatives not interested (50, 9%), language (38, 7%), and other (27, 5%). Of 73 enrolled patients, 45 (62%) contacted at least one relative to discuss GT within two months of enrollment. Twelve patients had at least one relative who participated in our facilitated referral pathway, but only 2 (3%) relatives completed GT through our pathway. Two additional relatives underwent GT separately. Of 20 patients who completed 3-month
more » ... ical impact questionnaires, 13 (65%) had no regret, and 19 (95%) had none to subclinical range stress. Conclusions Although over 50% of patients contacted family members regarding GT, only 3% had a relative undergo GT via our facilitated referral pathway. Comprehensive novel efforts to simplify access to GT for relatives are desperately needed.
doi:10.1136/ijgc-2022-igcs.262 fatcat:szj7v2dh4vdzrdcfhbtgxz2wya